| CASE REPORT |
|
| Ahead of Print |
|
|
Amlodipine-induced gingival hyperplasia: Case reports of two patients
G Sri Lakshmi1, G Tejaswini1, B Alekhya2, Maria Bethasaida Manuel2, R Ram2, V Siva Kumar2
1 Sri Venkateswara Institute of Medical Sciences Sri Padmavathi Medical College for Women, Tirupati, Andhra Pradesh, India
2 Department of Nephrology, Sri Venkateswara Institute of Medical Sciences, Tirupati, Andhra Pradesh, India
Correspondence Address:
R Ram,
Professor and Head, Sri Venkateswara Institute of Medical Sciences, Tirupati 517 507, Andhra Pradesh
India
 Source of Support: None, Conflict of Interest: None DOI: 10.4103/JCSR.JCSR_30_20
|
|
|
Drugs associated with gingival overgrowth fall into three broad categories – anticonvulsants, immune suppressants and calcium channel blockers. Amlodipine is a third-generation dihydropyridine. The prevalence of amlodipine-induced gingival hyperplasia is 4.2%. We report two patients with the amlodipine-induced gingival hyperplasia.
|
|
|
|
|
|
|
Search Pubmed for